Grinols, Earl L.; Henderson, James W. - In: PharmacoEconomics 25 (2007) 5, pp. 355-363
Pharmaceutical patents are anachronistic holdovers from an era in which modern economic understanding and tax tools were unavailable. Superior mechanisms lie somewhere between a first best pricing solution for the entire economy at one extreme and the current arrangements at the other. We...